MetaVia (MTVA) Exchange Rate Effect (2019 - 2022)
MetaVia's (MTVA) quarterly Exchange Rate Effect came in at -$1000.0 in Q1 2022, up 80.0% YoY from -$555.56 in Q1 2021, and little changed on a QoQ basis from -$1000.0 in Q4 2021.
MetaVia (MTVA) Exchange Rate Effect (2019 - 2022) Analysis & Trends
MetaVia (MTVA) has 4 years of Exchange Rate Effect data on file, last reported at -$1000.0 in Q1 2022.
- Quarterly Exchange Rate Effect rose 80.0% year-over-year to -$1000.0 in Q1 2022, while the trailing twelve-month figure through Mar 2022 was -$4000.0 (down 120.0% YoY) and the FY2021 annual result came in at -$8000.0, down 366.67% from the prior year.
- Exchange Rate Effect held at -$1000.0 in Q1 2022, from -$1000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $14000.0 in Q4 2019 to a low of -$22000.0 in Q1 2020.
- A 4-year average of $76.92 and a median of -$1000.0 in 2021 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 156.25% in 2020, down 633.33% in 2020.
- Tracing MTVA's Exchange Rate Effect over 4 years: stood at $14000.0 in 2019, then retreated by 7.14% to $13000.0 in 2020, then slumped by 107.69% to -$1000.0 in 2021, then changed by 0.0% to -$1000.0 in 2022.
- The last three Exchange Rate Effect figures came in at -$1000.0 (Q1 2022), -$1000.0 (Q4 2021), and $2000.0 (Q3 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | MetaVia | 8.72 Mn | -3.92 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -4,000.00 |
| Mar 31, 2021 | -5,000.00 |
| Mar 31, 2021 | -5,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Dec 31, 2020 | 13,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Sep 30, 2020 | 9,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Jun 30, 2020 | 3,000.00 |
| Mar 31, 2020 | -22,000.00 |
| Mar 31, 2020 | -22,000.00 |
| Dec 31, 2019 | 14,000.00 |
| Dec 31, 2019 | 14,000.00 |